# ANORO ELLIPTA
> **NDA203975** · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 2013-12-18
## Drug
- **FDA Application Number:** NDA203975
- **Application type:** New Drug Application
- **Brand name:** ANORO ELLIPTA
- **Generic name:** UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE
- **Active ingredients:** UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
- **Dosage form:** POWDER
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** GLAXOSMITHKLINE
- **Manufacturer:** Prasco Laboratories
- **First approval:** 2013-12-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203975)
---
*MORVS · CC0 1.0*